Alternatives to Cystic Fibrosis Foundation

Accelerating breakthroughs in prostate cancer diagnosis and treatment.

Venture philanthropy organization accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD).

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing novel therapeutics to restore gut lymphatic function.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biopharmaceutical company developing and commercializing CNS disease treatments.

A vertically-integrated procurement platform for the life sciences industry.

Enzyme-based technology to break down alcohol in the stomach.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Developing novel immunotherapies and diagnostics for cancer.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Accelerating patient access to evidence-based innovation in mental health.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

AI-powered precision testing for patient identification in clinics and clinical trials.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Developing gene editing therapies to lower cholesterol.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

AI-driven biotech company engineering novel proteins for therapeutics and sustainability.

A venture capital firm that operates multiple accelerators and invests in startups globally.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

AI-powered knowledge discovery for life sciences.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

Engineering scalable gene therapies for broader patient populations.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Developing oral small molecule medicines for immunological and chronic diseases.